Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Cytogen announces 1996 fiscal results

March 6, 1997

Clinical results for Murex/Innogenetics HIV-1 RT test

March 5, 1997

Akzo Nobel discloses MAb for HCV detection

March 5, 1997

ChemTrak H. pylori test approved

March 5, 1997

Hemagen's CMV diagnostic cleared for marketing

March 4, 1997

RCT discloses compounds for radiolabeling leukocytes/lymphocytes

March 4, 1997

Latex diagnostic cleared for U.S. market

March 3, 1997

Neoprobe's peptides for surgical cancer detection covered by patent

Feb. 28, 1997

Approval recommended for ultrasound contrast agent

Feb. 26, 1997

New contrast agents from Guerbet

Feb. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...